Serological, genetic and clinical associations with increased health-care resource utilization in inflammatory bowel disease

An inflammatory bowel disease–risk variant in INAVA decreases pattern recognition receptor–induced outcomes

(2017) Jie Yan et al.   JOURNAL OF CLINICAL INVESTIGATION

Examining Measures of Income and Poverty in Medicare Administrative Data

(2017) Lok Wong Samson et al.   MEDICAL CARE

Fine-mapping inflammatory bowel disease loci to single-variant resolution

(2017) Hailiang Huang et al.   NATURE

Chemokine and cytokine levels in inflammatory bowel disease patients

(2016) Udai P. Singh et al.   CYTOKINE

Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study

(2016) Isabelle Cleynen et al.   LANCET

Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Inception Cohort

(2015) Johan Burisch et al.   INFLAMMATORY BOWEL DISEASES

Infliximab to Treat Refractory Inflammation After Pelvic Pouch Surgery for Ulcerative Colitis

(2015) Orlaith B. Kelly et al.   Journal of Crohns & Colitis

Health-Related Utility Weights in a Cohort of Real-World Crohn’s Disease Patients

(2015) Dan Greenberg et al.   Journal of Crohns & Colitis

Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations

(2015) Jimmy Z Liu et al.   NATURE GENETICS

Ulcerative Colitis-Associated Hospitalization Costs: A Population-Based Study

(2015) Stephanie Coward et al.   Canadian Journal of Gastroenterology and Hepatology

IBD Candidate Genes and Intestinal Barrier Regulation

(2014) Declan F. McCole   INFLAMMATORY BOWEL DISEASES

Serologic Markers Associated with Development of Crohn’s Disease After Ileal Pouch Anal Anastomosis for Ulcerative Colitis

(2013) Brindusa Truta et al.   DIGESTIVE DISEASES AND SCIENCES

Predictors for hospitalization and outpatient visits in patients with inflammatory bowel disease

(2013) Michael C. Sulz et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Medical resource utilization and associated costs in patients with ulcerative colitis in the UK

(2013) Keith Bodger et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Association Between Variants of PRDM1 and NDP52 and Crohn's Disease, Based on Exome Sequencing and Functional Studies

(2013) David Ellinghaus et al.   GASTROENTEROLOGY

Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade

(2013) Junjie Xu et al.   Gastroenterology Research and Practice

ASCA IgG and CBir Antibodies Are Associated with the Development of Crohn’s Disease and Fistulae Following Ileal Pouch-Anal Anastomosis

(2012) Jennifer A. Coukos et al.   DIGESTIVE DISEASES AND SCIENCES

Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study

(2012) Mirthe Emilie van der Valk et al.   GUT

Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease

(2012) Luke Jostins et al.   NATURE

Analysis of IL12B Gene Variants in Inflammatory Bowel Disease

(2012) Jürgen Glas et al.   PLoS One

Antimicrobial Antibodies Are Associated With a Crohn's Disease–Like Phenotype After Ileal Pouch–Anal Anastomosis

(2011) Andrea D. Tyler et al.   Clinical Gastroenterology and Hepatology

NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant inNCF2that results in reduced binding to RAC2

(2011) Aleixo M Muise et al.   GUT

Direct Medical Cost of Managing IBD Patients: A Canadian Population-based Study

(2011) Charles N. Bernstein et al.   INFLAMMATORY BOWEL DISEASES

Cost Effectiveness of Treatments for Inflammatory Bowel Disease

(2011) Keith Bodger   PHARMACOECONOMICS

TNFAIP3 Maintains Intestinal Barrier Function and Supports Epithelial Cell Tight Junctions

(2011) Lauren E. Kolodziej et al.   PLoS One

Role of EP4 receptor and prostaglandin transporter in prostaglandin E2-induced alteration in colonic epithelial barrier integrity

(2010) Manigandan Lejeune et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation

(2010) Shane Crotty et al.   NATURE IMMUNOLOGY

Cost-effectiveness of biological therapy for Crohn’s disease: Markov cohort analyses incorporating United Kingdom patient-level cost data

(2009) K. BODGER et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease

(2009) Geoffrey C. Nguyen et al.   INFLAMMATORY BOWEL DISEASES

A model of the long-term cost effectiveness of scheduled maintenance treatment with infliximab for moderate-to-severe ulcerative colitis

(2008) H. H. TSAI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Both Preoperative Perinuclear Antineutrophil Cytoplasmic Antibody and Anti-CBir1 Expression in Ulcerative Colitis Patients Influence Pouchitis Development After Ileal Pouch–Anal Anastomosis

(2008) Phillip Fleshner et al.   Clinical Gastroenterology and Hepatology

Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults

(2008) Michael D. Kappelman et al.   GASTROENTEROLOGY

Confirmation of association of IRGM and NCF4 with ileal Crohn's disease in a population-based cohort

(2008) R L Roberts et al.   GENES AND IMMUNITY

Risk factors for pouch failure in patients with different phenotypes of Crohnʼs disease of the pouch

(2008) Bo Shen et al.   INFLAMMATORY BOWEL DISEASES

Socioeconomic deprivation does not influence the severity of Crohnʼs disease

(2008) Stéphane Nahon et al.   INFLAMMATORY BOWEL DISEASES

New links to the pathogenesis of Crohn disease provided by genome-wide association scans

(2007) Christopher G. Mathew   NATURE REVIEWS GENETICS